BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 24560809)

  • 1. GP73, a new marker for diagnosing HBV-ACLF in population with chronic HBV infections.
    Wei H; Zhang J; Li H; Ren H; Hao X; Huang Y
    Diagn Microbiol Infect Dis; 2014 May; 79(1):19-24. PubMed ID: 24560809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum gp73 is also a biomarker for diagnosing cirrhosis in population with chronic HBV infection.
    Qiao Y; Chen J; Li X; Wei H; Xiao F; Chang L; Zhang R; Hao X; Wei H
    Clin Biochem; 2014 Nov; 47(16-17):216-22. PubMed ID: 25168922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection and evaluation of serum GP73, a resident Golgi glycoprotein, as a marker in diagnosis of hepatocellular carcinoma].
    Zhao XY; Li N; Ding HG; Jiang FF
    Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):943-5. PubMed ID: 21223806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of miRNA in patients with hepatitis B virus-associated acute-on-chronic liver failure.
    Wen Y; Peng SF; Fu L; Fu XY; Wu DX; Liu BJ; Tan DM; Ouyang Y
    Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):126-132. PubMed ID: 29602672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Survey of the serum hepatocellular carcinoma marker Golgi glycoprotein (GP73) among Qidong residents and correlation analysis to outcome at two-year follow-up].
    Chen JG; Zhu YR; Lu WZ; Zhang YH; Lu JH
    Zhonghua Gan Zang Bing Za Zhi; 2012 Oct; 20(10):780-4. PubMed ID: 23207341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower level of complement component C3 and C3a in the plasma means poor outcome in the patients with hepatitis B virus related acute-on-chronic liver failure.
    Li Q; Lu Q; Zhu MQ; Huang C; Yu KK; Huang YX; Zhao X; Luo XG; Zheng JM
    BMC Gastroenterol; 2020 Apr; 20(1):106. PubMed ID: 32293297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relation between serum levels of high mobility group box 1 and hepatitis B virus-related acute-on-chronic liver failure].
    Duan XZ; Hu JH; Li C; Liu FF; Liu XY; Tong JJ; Xin SJ
    Zhonghua Gan Zang Bing Za Zhi; 2013 Jun; 21(6):434-7. PubMed ID: 24034844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of serum GP73 and p62 measurement to predict short-term prognosis in patients with HBV-related acute-on-chronic liver failure].
    Gao W; Gao H; Yin CM; Yang SL; Fan XH; Liu CL; Li XQ; Jia NN
    Zhonghua Gan Zang Bing Za Zhi; 2021 Sep; 29(9):855-860. PubMed ID: 34638204
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum soluble ST2 is a promising prognostic biomarker in HBV-related acute-on-chronic liver failure.
    Jiang SW; Wang P; Xiang XG; Mo RD; Lin LY; Bao SS; Lu J; Xie Q
    Hepatobiliary Pancreat Dis Int; 2017 Apr; 16(2):181-188. PubMed ID: 28381383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of circulating miR-125b-5p predicts survival in chronic hepatitis B patients with acute-on-chronic liver failure.
    Tao YC; Wang ML; Wang M; Ma YJ; Bai L; Feng P; Chen EQ; Tang H
    Dig Liver Dis; 2019 Mar; 51(3):412-418. PubMed ID: 30274791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical application of serum Golgi protein 73 in the diagnosis and progress of hepatocellular carcinoma].
    Zhao Y; Li Y; Hu B; He X; Huang J; Zhan M; Lu L
    Zhonghua Yi Xue Za Zhi; 2014 Feb; 94(5):390-2. PubMed ID: 24746091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of serum Golgi protein 73 as a biomarker for the diagnosis of significant fibrosis in patients with chronic HBV infection.
    Cao Z; Li Z; Wang Y; Liu Y; Mo R; Ren P; Chen L; Lu J; Li H; Zhuang Y; Liu Y; Wang X; Zhao G; Tang W; Xiang X; Wang H; Cai W; Liu L; Zhu C; Bao S; Xie Q
    J Viral Hepat; 2017 Nov; 24 Suppl 1():57-65. PubMed ID: 29082644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble ST2 plasma concentrations predict mortality in HBV-related acute-on-chronic liver failure.
    Lei Z; Mo Z; Zhu J; Pang X; Zheng X; Wu Z; Wang K; Li X; Xie D; Gao Z
    Mediators Inflamm; 2015; 2015():535938. PubMed ID: 25892854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-myc and STAT interactor correlates with severity and prognosis in acute-on-chronic liver failure of hepatitis B virus.
    Xiong L; Du Y; Zhou T; Du B; Visalath P; Lin L; Bao S; Cai W
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1800-1808. PubMed ID: 30771232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum GP73, a marker for evaluating progression in patients with chronic HBV infections.
    Wei H; Li B; Zhang R; Hao X; Huang Y; Qiao Y; Hou J; Li X; Li X
    PLoS One; 2013; 8(2):e53862. PubMed ID: 23418424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of Golgi glycoprotein 73, a new tumor marker in diagnosis of hepatocellular carcinoma: a primary study].
    Mao YL; Yang HY; Xu HF; Sang XT; Lu X; Yang ZY; Zhang JC; Zhong SX; Huang JF; Zhang HB
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):948-51. PubMed ID: 18756964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble mannose receptor as a predictor of prognosis of hepatitis B virus-related acute-on-chronic liver failure.
    Li TP; Guan SH; Wang Q; Chen LW; Yang K; Zhang H
    World J Gastroenterol; 2019 Oct; 25(37):5667-5675. PubMed ID: 31602166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of the relationship between hepatitis B virus precore and basal core promoter mutations and acute-on-chronic liver failure].
    Ma XY; Han T; Pei YZ; Zhao ZG; Gao YT; Li Y; Jing L
    Zhonghua Gan Zang Bing Za Zhi; 2012 Sep; 20(9):644-8. PubMed ID: 23207226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of M30/M65 for outcome of hepatitis B virus-related acute-on-chronic liver failure.
    Zheng SJ; Liu S; Liu M; McCrae MA; Li JF; Han YP; Xu CH; Ren F; Chen Y; Duan ZP
    World J Gastroenterol; 2014 Mar; 20(9):2403-11. PubMed ID: 24605039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokines elevated in patients with HBV-related acute-on-chronic liver failure promote NK cell mediated cytotoxicity through TRAIL.
    Wan Z; Xie G; Wu Y; Liu F; Xin S; You S; Liu H; Li C; Li D
    Dig Liver Dis; 2016 May; 48(5):528-535. PubMed ID: 26860239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.